NAVIDEA BIOPHARMACEUTICALS, INC. Separation Agreements
3 Contracts & Agreements
- Separation & Release Agreement effective March 30, 2023 between Navidea Biopharmaceuticals, Inc. and Michael Rosol (Filed With SEC on March 31, 2023)
- Separation Agreement and General Release between the Company and Jed A. Latkin (Filed With SEC on November 26, 2021)
- SEPARATION AGREEMENT AND RELEASE (Filed With SEC on June 2, 2014)
